Bellicum Pharmaceuticals Announces Pricing of Public Offering of Common Stock Read more about Bellicum Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Bellicum Pharmaceuticals Announces Proposed Public Offering of Common Stock Read more about Bellicum Pharmaceuticals Announces Proposed Public Offering of Common Stock
Bellicum Pharmaceuticals Provides Operational Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 Read more about Bellicum Pharmaceuticals Provides Operational Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016
Bellicum Pharmaceuticals to Present at the Barclays Global Healthcare Conference Read more about Bellicum Pharmaceuticals to Present at the Barclays Global Healthcare Conference
Bellicum to Report Fourth Quarter and Full Year 2016 Financial Results and Host Conference Call and Webcast on March 13, 2017 Read more about Bellicum to Report Fourth Quarter and Full Year 2016 Financial Results and Host Conference Call and Webcast on March 13, 2017
Bellicum Presents Updated Clinical Results at 2017 BMT Tandem Meetings on BPX-501 in Orphan Inherited Blood Disorders and Hematologic Cancers Read more about Bellicum Presents Updated Clinical Results at 2017 BMT Tandem Meetings on BPX-501 in Orphan Inherited Blood Disorders and Hematologic Cancers
Bellicum Announces Initiation of Patient Dosing with Controllable CAR T-Cell Product Candidate Read more about Bellicum Announces Initiation of Patient Dosing with Controllable CAR T-Cell Product Candidate
Bellicum Announces Appointment of Rick Fair as Chief Executive Officer in Preparation for Commercialization of BPX-501 and Next Phase of Growth Read more about Bellicum Announces Appointment of Rick Fair as Chief Executive Officer in Preparation for Commercialization of BPX-501 and Next Phase of Growth
Adaptimmune and Bellicum Pharmaceuticals Enter a Strategic Collaboration to Evaluate Next-Generation T-Cell Therapies Read more about Adaptimmune and Bellicum Pharmaceuticals Enter a Strategic Collaboration to Evaluate Next-Generation T-Cell Therapies
Bellicum Presents Clinical Results to Date of BPX-501 Pediatric Program and Provides Regulatory Update at Investor Event During ASH Annual Meeting Read more about Bellicum Presents Clinical Results to Date of BPX-501 Pediatric Program and Provides Regulatory Update at Investor Event During ASH Annual Meeting